Mednet Logo
HomePrimary Care
Primary Care

Primary Care

Physician perspectives on preventive care, chronic disease management, and evidence-based primary care practice.

Recent Discussions

Which class(es) of antihypertensives do you recommend for first-line therapy for hypertension in severe aortic stenosis?

2
1 Answers

Mednet Member
Mednet Member
Cardiology · Heart And Sleep Clinics Of America

Most beneficial data on ACE inhibitors.B blockers are to be avoided if associated AR but prior apparent contradiction is no longer valid and some benefit in outcomes based on their effects. Exact Aortic Stenosis substrate and comorbidities to determine which drugs to benefit. ARB's role is probably ...

What treatment would you offer a patient with extensive lymphangioma circumscriptum intermittently covering the entire abdomen?

1 Answers

Mednet Member
Mednet Member
Dermatology · Emory University School of Medicine

I would consider sirolimus (rapamycin) to shrink the lesion to a size that could be surgically excised.

What is your approach to differentiating diabetes insipidus from primary polydipsia in the outpatient setting?

1
1 Answers

Mednet Member
Mednet Member
Endocrinology · Kaiser Permanente Oakland Medical Center Endocrinology

I usually do overnight dehydration tests for 12 hours and if fasting AM urine osmolality is >600 DI is less likely. If urine osmolality is low with high serum sodium it indicates DI, whereas with primary polydipsia the serum sodium is low with low urine osmolality.

What is your approach for severe SCLE in patients unable to tolerate HCQ?

4
3 Answers

Mednet Member
Mednet Member
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)

30% of subacute cutaneous lupus erythematosus (SCLE) is worsened by or caused by drugs, especially PPIs, calcium channel blockers (CCBs), thiazides, minocycline, and anti-fungal meds. Very different from other drug-induced disorders, the culprit drug could have been started months to years (as long...

How do you approach a patient with stoma bag adhesive allergic contact dermatitis?

5
1 Answers

Mednet Member
Mednet Member
Dermatology · North Atlanta Dermatology Duluth

To keep the area dry, I have patients use Cavilon spray and Skins, an antimicrobial spray.

What is your approach to DVT prophylaxis in patients who require IVIG but are at increased risk for thrombotic events?

2
2 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

I am unaware of any published data to guide the decision-making for this topic. Empirically, I recommend low-dose aspirin in patients >50 who have to get long-term IVIG especially if there are a lot of underlying risk factors for thrombosis like diabetes, immobility, etc. Again, this is not an evide...

Are there any varying treatment considerations to make when managing patients with carbonate apatite versus hydroxyapatite kidney stones?

2
1 Answers

Mednet Member
Mednet Member
Nephrology · Mayo Clinic

Both of these stone types require a relatively alkaline urine to crystallize. Not surprisingly, they are often found in combination within the same stone. My diagnostic and treatment considerations do not depend on which mineral composition predominates. Stephen B Erickson, MD

How do you use CD4% in clinical practice in management of patients living with HIV?

2
7 Answers

Mednet Member
Mednet Member
Infectious Disease · Emory University School of Medicine

Perhaps a slightly different perspective: The CD4 percentage is invaluable in specific scenarios. Since the absolute CD4 count depends on the total WBC count and the lymphocyte percentage, the CD4 count can vary widely based on context, while the CD4 percentage is typically the more stable and relia...

How do you utilize cytokine panels in your clinical practice?

3
1 Answers

Mednet Member
Mednet Member
Rheumatology · Massachusetts General Hospital

It's become easier to order cytokine panels that get processed locally in my hospital. However, I think we're still far from knowing how to interpret these or make clinical changes as a result. While it's tempting to think, "If TNF is elevated, I will give the patient a TNF inhibitor, which will mak...

Is it better to give dose 2 of the mRNA 2024-2025 Covid-19 vaccine at month 2 or month 6 after dose 1 in moderately immunocompromised patients?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Cleveland Clinic

This is a complicated question and unfortunately, we have no clear answer for it based upon clinical outcome data. The COVID-19 pandemic has changed dramatically since its inception over 4 years ago. Based on a combination of favorable viral evolution of diminishing pathogenic potential continuing t...